medigraphic.com

2009, Number S1

<< Back Next >>

Rev Mex Anest 2009; 32 (S1)

Perioperative stress testing: The new high risk paradigm

Rozner MA

Language: English
References: 32
Page: 198-206
PDF size: 107.26 Kb.


Text Extraction

INTRODUCTION

For sometime, anesthesiologists have been asked to assist in the assignment of risk for an operative procedure, especially the patient with cardiac disease. For most of these patients, the preoperative assessment involves a decision about getting a stress test and dealing with the results. But there is little data to support this practice, and recent events suggesting that mechanical coronary artery intervention actually increases perioperative risk of MI and death have muddied the perioperative water.


REFERENCES

  1. Saklad M. Grading of patients for surgical procedures. Anesthesia 1941;2:281-84.

  2. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297(16):845-50.

  3. Eagle KA, Brundage BH, Chaitman BR, et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery. Circulation 1996;93(6):1278-317.

  4. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Circulation. Published 9/27/07. Available at: http://circ.ahajournals.org/cgi/content/short/116/17/e418. Accessed 4/1/09.

  5. Gibbons RJ, Bricker JT, Chaitman BR, et al. ACC/AHA 2002 guideline update for exercise testing. Published 02. Available at: http://www.acc.org/qualityandscience/clinical/guidelines/exercise/exercise_clean.pdf. Accessed 4/1/09.

  6. Baron JF, Mundler O, Bertrand M, et al. Dipyridamole-thallium scintigraphy and gated radionuclide angiography to assess cardiac risk before abdominal aortic surgery. N Engl J Med 1994;330(10):663-69.

  7. Sketch MH, Mohiuddin SM, Lynch JD, Zencka AE, Runco V. Significant sex differences in the correlation of electrocardiographic exercise testing and coronary arteriograms. Am J Cardiol 1975;36(2):169-73.

  8. Thompson C, Bergstrome D, Parlow JL. Limitations of preoperative dobutamine stress echocardiography in identifying severe left main coronary artery stenosis: a report of two cases and a brief review. Can J Anaesth 2003;50(9):933-39.

  9. Froehlich JB, Karavite D, Russman PL, et al. American College of Cardiology/American Heart Association preoperative assessment guidelines reduce resource utilization before aortic surgery. J Vasc Surg 2002;36(4):758-63.

  10. Morgan PB, Panomitros GE, Nelson AC, Smith DF, Solanki DR, Zornow MH. Low utility of dobutamine stress echocardiograms in the preoperative evaluation of patients scheduled for noncardiac surgery. Anesth Analg 2002;95(3):512-16.

  11. Pierpont GL, Moritz TE, Goldman S, et al. Disparate opinions regarding indications for coronary artery revascularization before elective vascular surgery. Am J Cardiol 2004;94(9):1124-28.

  12. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004;351(27):2795-804.

  13. Poldermans D, Schouten O, Vidakovic R, et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol 2007;49(17):1763-69.

  14. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999;341(24):1789-94.

  15. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996;335(23):1713-20.

  16. Poldermans D, Bax JJ, Kertai MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003;107(14):1848-51.

  17. Laufs U, Nef H, Mollmann H, Custodis F, Bohm M. Clinical Trial Updates and Hotline Sessions presented at the Scientific Session 2007 of the American heart association. Clin Res Cardiol 2008;97(1):1-11.

  18. Pitt B, Waters D, Brown WV, et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med 1999;341(2):70-76.

  19. Tu JV, Pashos CL, Naylor CD, et al. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N Engl J Med 1997;336(21):1500-1505.

  20. Hambrecht R, Walther C, Mobius-Winkler S, et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation 2004;109(11):1371-78.

  21. Jabbour S, Young-Xu Y, Graboys TB, et al. Long-term outcomes of optimized medical management of outpatients with stable coronary artery disease. Am J Cardiol 2004;93(3):294-99.

  22. Boden WE, O’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356(15):1503-16.

  23. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006;113(24):2803-9.

  24. Rabbitts JA, Nuttall GA, Brown MJ, et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008;109(4):596-604.

  25. Nuttall GA, Brown MJ, Stombaugh JW, et al. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 2008;109(4):588-95.

  26. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000;35(5):1288-94.

  27. Vicenzi MN, Ribitsch D, Luha O, Klein W, Metzler H. Coronary artery stenting before noncardiac surgery: more threat than safety? Anesthesiology 2001;94(2):367-68.

  28. Sharma AK, Ajani AE, Hamwi SM, et al. Major noncardiac surgery following coronary stenting: when is it safe to operate? Catheter Cardiovasc Interv 2004;63(2):141-45.

  29. Murphy JT, Fahy BG. Thrombosis of sirolimus-eluting coronary stent in the postanesthesia care unit. Anesth Analg 2005;101(4):971-73.

  30. Smith SC Jr., Feldman TE, Hirshfeld JW Jr., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006;113:156-75.

  31. Grines CL, Bonow RO, Casey DE Jr., et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007;115(6):813-18.

  32. Moscucci M, Eagle KA. Coronary revascularization before noncardiac surgery. N Engl J Med 2004;351(27):2861-63.




2020     |     www.medigraphic.com